Skip to content

Clinical trials

Phase 3 Ventricular Dysfunction, Left trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ventricular Dysfunction, Left Phase: Phase 3 Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20051
20061
20092
20112
20121
20135
20141
20153
20161
20191
20202
20221
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting4
Terminated4
Unknown status2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
Bayer2
Heart Care Foundation2
RWTH Aachen University2
Abbott Medical Devices1
Asan Medical Center1
Asklepios proresearch1
Aspirus Heart and Vascular Institute-Research and Education1
Baylor Research Institute1
BioControl Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ventricular Dysfunction, Left29
Heart Failure4
Diabetes Mellitus, Type 23
Coronary Artery Disease2
Myocardial Infarction2
Non-ST Elevated Myocardial Infarction2
ST Elevation Myocardial Infarction2
Anterior Wall Myocardial Infarction1
Breast Neoplasms1
Cardiac Output, Low1

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.